No abstract available
Keywords:
PD-1 (PDCD1); multiple myeloma; pembrolizumab.
Publication types
-
Clinical Trial, Phase I
-
Multicenter Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Antineoplastic Agents, Immunological / therapeutic use*
-
Cohort Studies
-
Female
-
Humans
-
Male
-
Multiple Myeloma / drug therapy*
-
Multiple Myeloma / mortality
-
Recurrence
-
Survival Analysis
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
pembrolizumab
Associated data
-
ClinicalTrials.gov/NCT01953692